Growth Metrics

Collegium Pharmaceutical (COLL) Treasury Shares (2016 - 2026)

Collegium Pharmaceutical has reported Treasury Shares over the past 7 years, most recently at $222.5 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 12.66% year-over-year to $222.5 million; the TTM value through Dec 2025 reached $222.5 million, up 12.66%, while the annual FY2025 figure was $222.5 million, 12.66% up from the prior year.
  • Treasury Shares for Q4 2025 was $9.0 million at Collegium Pharmaceutical, roughly flat from $9.0 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $9.0 million in Q3 2025 and troughed at -$859040.0 in Q3 2021.
  • A 5-year average of $3.5 million and a median of $2.6 million in 2022 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: soared 210.54% in 2022 and later rose 12.66% in 2025.
  • Year by year, Treasury Shares stood at $42.9 million in 2021, then soared by 44.48% to $61.9 million in 2022, then surged by 121.85% to $137.4 million in 2023, then skyrocketed by 43.76% to $197.5 million in 2024, then increased by 12.66% to $222.5 million in 2025.
  • Business Quant data shows Treasury Shares for COLL at $222.5 million in Q4 2025, $222.5 million in Q3 2025, and $217.5 million in Q2 2025.